The expression level of DLGAP5 was negatively correlated with the prognosis of patients, and silencing DLGAP5 can cause cell-cycle arrest and inhibit NSCLC cell proliferation (Love, Huber & Anders, 2014). Here, DLGAP5 is linked to non-small cell lung carcinoma.